INDIA —Kedaara Capital has completed a US$ 200 million equity investment in Tynor Orthotics Private Limited, marking one of the largest private equity injections into India's consumer healthcare and medical equipment segment. The capital deployment will support Tynor's strategic transition into a global orthopaedic platform by expanding its domestic retail network and boosting international presence across key export regions.
Founded in 1993, Tynor Orthotics is a manufacturer of orthopaedic supports, rehabilitation equipment, and mobility aids. The enterprise operates three production facilities spanning 650,000 square feet and distributes its products across more than 300,000 retail outlets and 8,000 hospitals spanning 60 countries.
The investment reflects accelerating institutional capital inflows into India's rapidly expanding medical devices and consumer med-tech sectors. As healthcare demand grows across developing economies, cost-effective manufacturing hubs capable of meeting global quality standards are attracting substantial private equity interest. Tynor's established distribution footprint and lean manufacturing framework present a direct model for scaling Indian med-tech platforms into international markets.
For global investors and healthcare stakeholders, the deal signals strong market confidence in specialized orthopaedic and rehabilitation products positioned between prescription medical devices and everyday consumer wellness solutions. Strategic alignment between Kedaara, Tynor's founders, and long-standing partner Thuasne is projected to drive operational efficiencies, enhance research and development, and deepen supply chain integration across both emerging and developed healthcare markets.
